Dow Up 0.48% Nasdaq Up 0.43%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
2.33 0.10(4.12%) Aug 19, 4:00PM EDT
Prev Close:2.43
Open:2.43
Bid:2.21 x 100
Ask:3.26 x 1000
1y Target Est:6.00
Beta:1.05
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.28 - 2.43
52wk Range:1.66 - 7.77
Volume:2,941,315
Avg Vol (3m):3,114,060
Market Cap:275.42M
P/E (ttm):N/A
EPS (ttm):-0.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALE

Comparison

Symbol% ChgMkt Cap
GALEDown 4.12%275.42M
CELG73.04B
VSTM233.09M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):41.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.41
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback